04 July 2025 : Clinical Research
Comparative Analysis of Afamin, Asprosin, and Pentraxin 3 Levels in Women with PCOS and Women with Unexplained Infertility
Mehmet Kursat Derici ABCDEF 1*, Engin Yıldırım ABCDEFG 2DOI: 10.12659/MSM.947895
Med Sci Monit 2025; 31:e947895
Table 2 Comparison of biochemical data of patients with polycystic ovary syndrome and women with unexplained ınfertility.
| Unexplained infertile group (n=55)Mean±Std/Median (min–max) | PCOS group (n=51)Mean±Std/Median (min–max) | P | |
|---|---|---|---|
| FSH (IU/L) | 4.9±1.26.0. (3.7–9.8) | 5.4±1.25.7 (2.3–7.8) | 0.102 |
| LH (IU/L) | 4.1±2.93.2 (2.5–7.1) | 5.9±2.23.8 (3.1–9.4) | * |
| AMH (ng/dL) | 3.4±2.13.6 (1.5–6.3) | 5.9±3.17.2 (3.4–8.8) | * |
| Estradiol (pg/mL) | 202.3±80.487.4. (66.2–309.5) | 304.1±108.3105.6 (94.6–489.4) | * |
| Progesterone (ng/mL) | 7.1±4.56.0 (3.5–11.8) | 8.4±5.94.8 (4.1–14.4) | 0.692 |
| Afamin (mg/L) | 36.1±24.741.6 (8.2–94.3) | 74.1±18.366.2 (14.9–98.4) | * |
| Pentraxin 3 (ng/mL) | 4.1±2.84.2 (3.6–7.4) | 8.6±3.47.1 (4.6–10.5) | * |
| Asprosin (ng/mL) | 3.7±2.94.1 (1.4–6.2) | 4.2±2.53.6 (1.9–7.1) | 0.264 |
| PCOS – polycystic ovary syndrome; FSH – follicle-stimulating hormone; LH – luteinizing hormone; AMH – anti-mullerian hormone. * | |||